title: [Neonatal hemorrhagic syndromes].
abstract: OBJECTIVE
  The purpose of our study was to clarify the frequency of these causes.
  
  
  METHODS
  Retrospective study using reports of newborns in the neonatal unit in Sousse (Tunisia) from 1991 to 1996, hospitalized for hemorrhagic syndrome defined by bleeding, exteriorized or not, whatever its importance, severity, causes and the associated clinical and biological disorders. Isolated meningeal hemorrhages, limited cutaneo-mucous hemorrhages (conjunctival hemorrhages, bruises), and genital crises of the newborn, were excluded.
  
  
  RESULTS
  One hundred and fifty-five hemorrhagic syndromes were observed from 7,128 newborn infants (2.17% of hospitalization). Sex ratio was 1.42. Prematurity rate was 35.7%. The Apgar score was < 7 at one minute in 40.7% of cases. Disorders associated with hemorrhagic syndromes were observed in 118 newborn infants (76.1%) with a predominance of neonatal infections (35.6%). The etiology of neonatal hemorrhages was specified in 93% of cases: newborn hemorrhagic disease (27.7%), disseminated intravascular coagulation (27.1%), isolated thrombocytopenia (9%), digestive lesions (13.5%), and obstetrical trauma (2.6%).
  
  
  CONCLUSIONS
  The frequency of the newborns hemorrhagic syndromes underlines the need for its systematic prevention by vitamin K in the antenatal period to the mother and after birth to the newborn.
authors.affiliation: Service de néonatologie, hôpital Farhat-Hached, 4000 Sousse, Tunisie.
authors.forename: N
authors.initials: N
authors.lastname: Salem
authors.forename: K
authors.initials: K
authors.lastname: Monastiri
authors.forename: K
authors.initials: K
authors.lastname: Bacha
authors.forename: N
authors.initials: N
authors.lastname: Guirat
authors.forename: H
authors.initials: H
authors.lastname: Sboui
authors.forename: S
authors.initials: S
authors.lastname: Jaidane
authors.forename: H
authors.initials: H
authors.lastname: Skouri
authors.forename: N
authors.initials: N
authors.lastname: Snoussi
mesh_terms: D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000209:etiology; D014812:Vitamin K / Q000627:therapeutic use*; D006475:Vitamin K Deficiency Bleeding / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy
chemical_list: D014812:Vitamin K